开能健康：子公司拟收购原能集团部分子公司股权

Core Viewpoint - The company announced a cash acquisition of 100% equity stakes in several subsidiaries of Yuan Neng Group, which will enhance its control over the cell industry value chain and create business synergies [1][2] Group 1: Acquisition Details - The acquisition involves Hainan Kaineng Cell acquiring 100% equity of Yuan Tian Biological, Lishui Dongxin, Kele Cat, and Jiyuan Meiyu from Yuan Neng Group [1] - The total transaction price is set at 203.82 million yuan [2] - The acquired companies are all under the same control of Yuan Neng Group, ensuring continuity in management and operational relationships post-acquisition [1] Group 2: Business Synergies - Yuan Tian Biological provides research and raw material support for Jiyuan Meiyu's cell factor cosmetics [1] - Yuan Tian Biological also offers technical support for pet health and anti-aging business to Laisenyuan [1] - Lishui Dongxin's subsidiary, Shanghai Dongxin, operates the Yuan Neng Pharmaceutical Park, indicating a tight business and ecological relationship among the acquired entities [1]